ABIOMED Inc
Change company Symbol lookup
Select an option...
ABMD ABIOMED Inc
ARMP Armata Pharmaceuticals Inc
K Kellogg Co
VIAV Viavi Solutions Inc
SOND Sonder Holdings Inc
SPHD Invesco S&P 500® High Dividend Low Volatility ETF
XPEV Xpeng Inc
VLTFF Volta Finance Ltd
PME Pingtan Marine Enterprise Ltd
ADMT ADM Tronics Unlimited Inc
Go

Health Care : Health Care Equipment & Supplies | Mid Cap Growth
Company profile

ABIOMED, Inc. is a medical technology provider, which provides circulatory support and oxygenation. The Company develops, manufactures and markets its products, which are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. Its products are used in the cardiac catheterization lab or cath lab, by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty, or heart surgery procedures. The Company's Impella device portfolio includes the Impella 2.5, Impella CP, Impella 5.0, Impella LD, Impella 5.5 and Impella RP devices. Its product pipeline includes Impella ECP, Impella XR Sheath, Impella BTR and precardiac. The Impella ECP device is designed for blood flow of greater than three and a half liters per minute. The Impella BTR device is designed to be a heart pump with integrated motors and sensors.

Closing Price
$256.49
Day's Change
7.41 (2.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
257.50
Day's Low
243.78
Volume
(Average)
Volume:
364,199

10-day average volume:
364,624
364,199

ABMD's position in the Health Care Equipment & Supplies industry

Industry PeersABMDBSXTFXLMATSTXS

Summary

Company ProfileABIOMED, Inc. is a medical technology provider, which provides circulatory support and oxygenation. The Company develops, manufactures and markets its products, which are designed to enable the heart...
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s business segments include MedSurg, Rhythm and Neuro, and Cardiovascular. The MedSurg segment...
Go to BSX summary
Teleflex Incorporated is a provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare...
Go to TFX summary
LeMaitre Vascular, Inc. is a provider of medical devices and human tissue cryopreservation services, which are used in the treatment of peripheral vascular disease, end-stage renal disease and to a...
Go to LMAT summary
Stereotaxis, Inc. designs, manufactures and markets robotic systems, instruments and information systems for the interventional laboratory. The Company's robotic technology, Robotic Magnetic...
Go to STXS summary
52-Week Change

VS. INDUSTRY
-18.12%
-12.56%
-37.15%
-25.94%
-80.19%
Market Cap

VS. INDUSTRY
$11.3B
$53.6B
$11.9B
$1.0B
$135.9M
Beta

VS. INDUSTRY
1.3
0.8
1.2
1.2
1.7
Dividend Yield

VS. INDUSTRY
--
--
0.54%
1.10%
--
P/E (TTM, GAAP)

VS. INDUSTRY
84.03x
71.39x
24.63x
36.68x
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$1.0B
$12.2B
$2.8B
$158.1M
$33.4M
Profit Margin

VS. INDUSTRY
13.23%
6.65%
17.31%
17.09%
-39.69%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
20.58%
22.21%
15.49%
17.88%
--
Revenue Growth (TTM)

VS. INDUSTRY
21.74%
20.14%
10.90%
17.38%
13.35%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.